Опыт применения шкал SCORE и SCORE2 для оценки риска сердечно-сосудистых осложнений у жителей Российской Федерации

A. V. Tregubov; A. A.  Tregubova; I. V. Alekseeva; K. I.  Savchuk; S. A.  Urazgildeeva

doi:10.34687/2219-8202.JAD.2022.03.0005

Authors

A. V. Tregubov
A. A. Tregubova
I. V. Alekseeva
K. I. Savchuk
S. A. Urazgildeeva https://orcid.org/0000-0003-3046-372X

DOI:

https://doi.org/10.34687/2219-8202.JAD.2022.03.0005

Keywords:

primary prevention of cardiovascular diseases, risk assessment, SCORE, SCORE 2

Abstract

The Objective of the study was to investigate the implementation of SCORE2 on cardiovascular disease risk assessment (CVD) in patients in the Russian Federation.

Material and methods: 100 patients aged 40 to 65 (48 male, mean age 55.2±7.1 years) were included into the study. For each patient entered in the study, the fatal risk of CVD was evaluated on the SCORE scale (with subsequent calculation of the total risk of fatal and non-fatal cardiovascular (CV) events according to the current gidelines) and the risk of fatal and non-fatal CV events on the SCORE2 scale. The SPSS software package, version 22.0 (SPSS Inc., USA) was used for statistical analysis.

Results. Risk assessment on the SCORE scale led to the following results: 23 patients were classified as low-risk CVD, 56 - as moderate-risk, 19 – as high risk, and 2 were very high-risk. The estimated risk of fatal and non-fatal CVD ranged from 0.3% to 53.2% and averaged 8.8±7.5%. According to SCORE2, all patients were classified as high risk and very high risk: 34 and 66 patients, respectively. The risk of fatal and non-fatal cardiovascular complications in the assessment was 11.5±5.7% and has rised on 2.7% in average compared with the risk determined by the SCORE system (p<0.001).

Conclusion: The use of the SCORE2 scale instead of SCORE lead to reclassify the majority of patients from low and moderate risk of CV events to high and very high risk. Implementation of the new risk assessment system will followed by more frequent use of high intensive therapy to achieve more strict treatment goals.

Downloads

Download data is not yet available.

References

Сайт Всемирной организации здравоохранения: сердечно-сосудистые заболевания. [Электронный ресурс]. 2017. 17 мая. URL: https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (дата обращения: 16.06.2022).

Jousilahti P., Laatikainen T., Peltonen M., Borodulin К., Männistö S., Jula A. et al. Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: Population based observational study. BMJ. 2016; 352. doi: 10.1136/bmj.i721.

Kalinina A.M., Ipatov P.V., Kushunina D.V., Egorov V.A., Drozdova L.Y., Boytsov S.A. Results of circulatory disease detection during prophylactic medical examination of the adult population: the first two years’ experience // Terapevticheskii arkhiv. - 2016. - Vol. 88. - N. 1. - P. 46-52. Russian. (Калинина А.М., Ипатов П.В., Кушунина Д.В., Егоров В.А., Дроздова Л.Ю., Бойцов С.А. Результаты выявления болезней системы кровообращения при диспансеризации взрослого населения: опыт первых 2 лет. Терапевтический архив. 2016;88(1):46-52). URL: https://ter-arkhiv.ru/0040-3660/article/view/31909

Алексеева Е. Российская сердечно-сосудистая катастрофа [Электронный ресурс] // Независимая газета. 2021. 18 мая. URL: https://www.ng.ru/health/2021-05-18/8_8150_catastrophe.html (дата обращения: 16.06.2022).

Boytsov S.A. Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Eganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian journal of cardiology. 2018;(6):7-122. Russian. (Бойцов С.А., Погосова Н.В., Бубнова М.Г., Драпкина О.М., Гаврилова Н.Е., Еганян Р.А. и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018;(6):7-122). doi: 10.15829/1560-4071-2018-6-7-122

Kukharchuk V.V., Ezhov M.V., Sergienko I.V., . Arabidze G.G., Bubnova M.G., Balakhonova T.V. Diagnosis and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations, VII revision. 2020;1(38):7-42). Russian. (Кухарчук В.В., Ежов М.В., Сергиенко И.В., Арабидзе Г.Г., Бубнова М.Г., Балахонова Т.В. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, VII пересмотр. 2020;1(38):7-42). doi: 10.34687/2219-8202.JAD.2020.01.0002

Sergienko I.V., Ansheles A.A., Boytsov S.A. Mobile application “Aterostop” for a comprehensive assessment of cardiovascular risk in patients in the Russian population. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;4(93):415-420. Russian. (Сергиенко И.В., Аншелес А.А., Бойцов С.А. Мобильное приложение Aterostop для комплексной оценки сердечно-сосудистого риска у пациентов в российской популяции. Терапевтический архив. 2021;4(93):415-420). doi: 10.26442/00403660.2021.04.200683.

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. doi:10.1093/eurheartj/ehab484.

SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021;42:2439-2454.

SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 2021;42:2455-2467.

Администрация Санкт-Петербурга. Официальный сайт: как меняется уровень курения в России. [Электронный ресурс]. 2020. 31 мая. URL: https://www.gov.spb.ru/gov/terr/reg_viborg/news/189687/ (дата обращения: 16.06.2022).

Министерство здравоохранения Российской Федерации. Официальный сайт: Михаил Мурашко: распространенность курения в России сократилась до 20,3% [Электронный ресурс]. 2022. 31 мая. URL: https://minzdrav.gov.ru/news/2022/05/31/18802-mihail-murashko-rasprostranennost-kureniya-v-rossii-sokratilas-do-20-3 (дата обращения: 16.06.2022).

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. ESC Scientific Document Group, 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104, https://doi.org/10.1093/eurheartj/ehy339.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart Journal, Volume 41, Issue 1, 1 January 2020, Pages 111–188, https://doi.org/10.1093/eurheartj/ehz455.